Survival prediction of gastric cancer by a seven-microRNA signature
- 30 November 2009
- Vol. 59 (5), 579-585
- https://doi.org/10.1136/gut.2008.175497
Abstract
Aims Several microarray studies have reported microRNA (miRNA) expression signatures that classify cancer patients into different prognostic groups. No study has evaluated the association between miRNA expression patterns and gastric cancer prognosis. In this study, we developed a seven-miRNA signature that is closely associated with survival of patients with gastric cancer. Patients and methods MiRNA expression profile was analysed by real-time RT-PCR in 100 gastric cancer patients, which were randomly assigned to either the training set or the testing set. Cox proportional hazard regression and risk-score analysis were used to identify a stage-independent set of seven-miRNA signature in the training set that could classify patients with significantly different prognosis. This miRNA signature was further validated by the testing set and an independent cohort 60 patients. Results We have identified a seven-miRNA signature (miR-10b, miR-21, miR-223, miR-338, let-7a, miR-30a-5p, miR-126) for overall survival (p=0.0009) and relapse-free survival (p=0.0005) of gastric cancer patients. Multivariate analysis shown that the risk signature was an independent predictor of overall survival (HR=3.046; 95% CI, 1.246 to 7.445, p=0.015) and relapse-free survival (HR=3.337; 95% CI, 1.298 to 8.580, p=0.012). Furthermore, the predictive value of this seven-miRNA signature was validated in the testing set of 50 patients and an independent set of 60 patients. Conclusion Our seven-miRNA signature is closely associated with relapse-free and overall survival among patients with gastric cancer. The prognostic signature could be applicable to future decisions concerning treatment.Keywords
This publication has 20 references indexed in Scilit:
- The cell growth suppressor, mir-126, targets IRS-1Biochemical and Biophysical Research Communications, 2008
- MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosisRNA, 2008
- The noncoding RNA, miR‐126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3‐kinase signaling and is frequently lost in colon cancersGenes, Chromosomes and Cancer, 2008
- MicroRNA-126 Regulates HOXA9 by Binding to the HomeoboxMolecular and Cellular Biology, 2008
- Disrupting the Pairing Between let-7 and Hmga2 Enhances Oncogenic TransformationScience, 2007
- MicroRNA Signatures in Human CancersNature Reviews Cancer, 2006
- Unique microRNA molecular profiles in lung cancer diagnosis and prognosisCancer Cell, 2006
- A MicroRNA Signature Associated with Prognosis and Progression in Chronic Lymphocytic LeukemiaThe New England Journal of Medicine, 2005
- MicroRNA Gene Expression Deregulation in Human Breast CancerCancer Research, 2005
- RAS Is Regulated by the let-7 MicroRNA FamilyCell, 2005